AS
Arumugam Sundhararajan
About Arumugam Sundhararajan
Data last updated:
Arumugam Sundhararajan is a Director at Toxiven Biotech Private Limited (since 2023). The company operates in Life Sciences. Toxiven Biotech Private Limited reported revenue of ₹1.74 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Toxiven Biotech Private Limited U24304TZ2019PTC031781 | Director | 22 Nov 2023 | 2019 | ₹1.74 Cr (FY 2025) | Active |
Board colleagues of Arumugam Sundhararajan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Harry Fonseca Williams | 08394353 | Toxiven Biotech Private Limited | Director |
| Mohanraj Vaiyapuri | 10827704 | Toxiven Biotech Private Limited | Director |
| Padmini Ramachandran | 10832319 | Toxiven Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Arumugam Sundhararajan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arumugam Sundhararajan
Arumugam Sundhararajan currently holds 1 directorship: Toxiven Biotech Private Limited (Director, since 22 Nov 2023, revenue ₹1.74 Cr (FY 2025)).
Arumugam Sundhararajan was first appointed on 22 Nov 2023 as Director at Toxiven Biotech Private Limited.
The current boards of Arumugam Sundhararajan's companies include Harry Fonseca Williams (Toxiven Biotech Private Limited), Mohanraj Vaiyapuri (Toxiven Biotech Private Limited), Padmini Ramachandran (Toxiven Biotech Private Limited).